nach oben

Diabetologia

Erschienen in:

01.06.2008 | Article

Human retinal pigment epithelium proteome changes in early diabetes

verfasst von: A. Decanini, P. R. Karunadharma, C. L. Nordgaard, X. Feng, T. W. Olsen, D. A. Ferrington

Erschienen in: Diabetologia | Ausgabe 6/2008

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Diabetic retinopathy is the most common complication of diabetes and a leading cause of blindness among working-age adults. Anatomical and functional changes occur in the retina and retinal pigment epithelium (RPE) prior to clinical symptoms of the disease. However, the molecular mechanisms responsible for these early changes, particularly in the RPE, remain unclear. To begin defining the molecular changes associated with pre-retinopathic diabetes, we conducted a comparative proteomics study of human donor RPE.

Methods

The RPE was dissected from diabetic human donor eyes with no clinically apparent diabetic retinopathy (n = 6) and from eyes of age-matched control donors (n = 17). Soluble proteins were separated based upon their mass and charge using two-dimensional (2-D) gel electrophoresis. Protein spots were visualised with a fluorescent dye and spot densities were compared between diabetic and control gels. Proteins from spots with significant disease-related changes in density were identified using mass spectrometry.

Results

Analysis of 325 spots on 2-D gels identified 31 spots that were either up- or downregulated relative to those from age-matched control donors. The protein identity of 18 spots was determined by mass spectrometry. A majority of altered proteins belonged to two major functional groups, metabolism and chaperones, while other affected categories included protein degradation, synthesis and transport, oxidoreductases, cytoskeletal structure and retinoid metabolism.

Conclusions/interpretation

Changes identified in the RPE proteome of pre-retinopathic diabetic donor eyes compared with age-matched controls suggest specific cellular alterations that may contribute to diabetic retinopathy. Defining the pre-retinopathic changes affecting the RPE could provide important insight into the molecular events that lead to this disease.

International Diabetes Federation (2005) Diabetes Atlas. Available from http://www.eatlas.idf.org/, last accessed January 2008

Klein R, Klein BE, Moss SE, Cruickshanks KJ (1998) The Wisconsin epidemiologic study of diabetic retinopathy: XVII The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 105:1801–1815PubMedCrossRef

Antonetti DA, Barber AJ, Bronson SK et al (2006) Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes 55:2401–2411PubMedCrossRef

Park SH, Park JW, Park SJ et al (2003) Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina. Diabetologia 46:1260–1268PubMedCrossRef

Aizu Y, Oyanagi K, Hu J, Nakagawa H (2002) Degeneration of retinal neuronal processes and pigment epithelium in the early stage of the streptozotocin-diabetic rats. Neuropathology 22:161–170PubMedCrossRef

Phipps JA, Fletcher EL, Vingrys AJ (2004) Paired-flash identification of rod and cone dysfunction in the diabetic rat. Invest Ophthalmol Vis Sci 45:4592–4600PubMedCrossRef

Bensaoula T, Ottlecz A (2001) Biochemical and ultrastructural studies in the neural retina and retinal pigment epithelium of STZ-diabetic rats: effect of captopril. J Ocul Pharmacol Ther 17:573–586PubMedCrossRef

Ramsey DJ, Ripps H, Qian H (2006) An electrophysiological study of retinal function in the diabetic female rat. Invest Ophthalmol Vis Sci 47:5116–5124PubMedCrossRef

Klemp K, Larsen M, Sander B, Vaag A, Brockhoff PB, Lund-Andersen H (2004) Effect of short-term hyperglycemia on multifocal electroretinogram in diabetic patients without retinopathy. Invest Ophthalmol Vis Sci 45:3812–3819PubMedCrossRef

10.

Steinberg RH (1985) Interactions between the retinal pigment epithelium and the neural retina. Doc Ophthalmol 60:327–346PubMedCrossRef

11.

Young TA, Wang H, Munk S et al (2005) Vascular endothelial growth factor expression and secretion by retinal pigment epithelial cells in high glucose and hypoxia is protein kinase C-dependent. Exp Eye Res 80:651–662PubMedCrossRef

12.

Foulds WS (1990) The choroidal circulation and retinal metabolism—an overview. Eye 4:243–248PubMed

13.

Quin GG, Len AC, Billson FA, Gillies MC (2007) Proteome map of normal rat retina and comparison with the proteome of diabetic rat retina: new insight in the pathogenesis of diabetic retinopathy. Proteomics 7:2636–2650PubMedCrossRef

14.

Wang YD, Wu JD, Jiang ZL et al (2007) Comparative proteome analysis of neural retinas from type 2 diabetic rats by two-dimensional electrophoresis. Curr Eye Res 32:891–901PubMedCrossRef

15.

Nordgaard CL, Berg KM, Kapphahn RJ et al (2006) Proteomics of the retinal pigment epithelium reveals altered protein expression at progressive stages of age-related macular degeneration. Invest Ophthalmol Vis Sci 47:815–822PubMedCrossRef

16.

Ethen CM, Reilly C, Feng X, Olsen TW, Ferrington DA (2006) The proteome of central and peripheral retina with progression of age-related macular degeneration. Invest Ophthalmol Vis Sci 47:2280–2290PubMedCrossRef

17.

Kapphahn RJ, Ethen CM, Peters EA, Higgins L, Ferrington DA (2003) Modified alpha A crystallin in the retina: altered expression and truncation with aging. Biochemistry 42:15310–15325PubMedCrossRef

18.

Olsen TW, Feng X (2004) The Minnesota Grading System of eye bank eyes for age-related macular degeneration. Invest Ophthalmol Vis Sci 45:4484–4490PubMedCrossRef

19.

Harris WA, Janecki DJ, Reilly JP (2002) Use of matrix clusters and trypsin autolysis fragments as mass calibrants in matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 16:1714–1722PubMedCrossRef

20.

Hoppe G, O'Neil J, Hoff HF, Sears J (2004) Products of lipid peroxidation induce missorting of the principal lysosomal protease in retinal pigment epithelium. Biochim Biophys Acta 1689:33–41PubMed

21.

Witmer AN, Vrensen GF, Van Noorden CJ, Schlingemann RO (2003) Vascular endothelial growth factors and angiogenesis in eye disease. Prog Retin Eye Res 22:1–29PubMedCrossRef

22.

Yamane K, Minamoto A, Yamashita H et al (2003) Proteome analysis of human vitreous proteins. Mol Cell Proteomics 2:1177–1187PubMedCrossRef

23.

West KA, Yan L, Shadrach K et al (2003) Protein database, human retinal pigment epithelium. Mol Cell Proteomics 2:37–49PubMedCrossRef

24.

Ouchi M, West K, Crabb JW, Kinoshita S, Kamei M (2005) Proteomic analysis of vitreous from diabetic macular edema. Exp Eye Res 81:176–182PubMedCrossRef

25.

Patel JI, Tombran-Tink J, Hykin PG, Gregor ZJ, Cree IA (2006) Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: implications for structural differences in macular profiles. Exp Eye Res 82:798–806PubMedCrossRef

26.

Nakanishi T, Koyama R, Ikeda T, Shimizu A (2002) Catalogue of soluble proteins in the human vitreous humor: comparison between diabetic retinopathy and macular hole. J Chromatogr B Analyt Technol Biomed Life Sci 776:89–100PubMedCrossRef

27.

Bishop PN, Takanosu M, Le Goff M, Mayne R (2002) The role of the posterior ciliary body in the biosynthesis of vitreous humour. Eye 16:454–460PubMedCrossRef

28.

Crowther GJ, Milstein JM, Jubrias SA, Kushmerick MJ, Gronka RK, Conley KE (2003) Altered energetic properties in skeletal muscle of men with well-controlled insulin-dependent (type 1) diabetes. Am J Physiol Endocrinol Metab 284:E655–E662PubMed

29.

Simoneau JA, Kelley DE (1997) Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. J Appl Physiol 83:166–171PubMed

30.

Stanley WC, Lopaschuk GD, McCormack JG (1997) Regulation of energy substrate metabolism in the diabetic heart. Cardiovasc Res 34:25–33PubMedCrossRef

31.

McLean MP, Billheimer JT, Warden KJ, Irby RB (1995) Differential expression of hepatic sterol carrier proteins in the streptozotocin-treated diabetic rat. Endocrinology 136:3360–3368PubMedCrossRef

32.

Tessari P, Puricelli L, Iori E et al (2007) Altered chaperone and protein turnover regulators expression in cultured skin fibroblasts from type 1 diabetes mellitus with nephropathy. J Proteome Res 6:976–986PubMedCrossRef

33.

Puricelli L, Iori E, Millioni R et al (2006) Proteome analysis of cultured fibroblasts from type 1 diabetic patients and normal subjects. J Clin Endocrinol Metab 91:3507–3514PubMedCrossRef

34.

Ola MS, Berkich DA, Xu Y et al (2006) Analysis of glucose metabolism in diabetic rat retinas. Am J Physiol Endocrinol Metab 290:E1057–E1067PubMedCrossRef

35.

Borges JC, Ramos CH (2005) Protein folding assisted by chaperones. Protein Pept Lett 12:257–261PubMedCrossRef

36.

Yao Y, Zhou Y, Wang C (1997) Both the isomerase and chaperone activities of protein disulfide isomerase are required for the reactivation of reduced and denatured acidic phospholipase A2. Embo J 16:651–658PubMedCrossRef

37.

Yoshida H (2007) ER stress and diseases. Febs J 274:630–658PubMedCrossRef

38.

Nozaki J, Kubota H, Yoshida H et al (2004) The endoplasmic reticulum stress response is stimulated through the continuous activation of transcription factors ATF6 and XBP1 in Ins2+/Akita pancreatic beta cells. Genes Cells 9:261–270PubMedCrossRef

39.

Laybutt DR, Preston AM, Akerfeldt MC et al (2007) Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes. Diabetologia 50:752–763PubMedCrossRef

40.

Ohta S, Ohsawa I (2006) Dysfunction of mitochondria and oxidative stress in the pathogenesis of Alzheimer’s disease: on defects in the cytochrome c oxidase complex and aldehyde detoxification. J Alzheimers Dis 9:155–166PubMed

41.

van Reyk DM, Gillies MC, Davies MJ (2003) The retina: oxidative stress and diabetes. Redox Rep 8:187–192PubMedCrossRef

42.

Ellis EM (2007) Reactive carbonyls and oxidative stress: potential for therapeutic intervention. Pharmacol Ther 115:13–24PubMedCrossRef

43.

Dhalla NS, Liu X, Panagia V, Takeda N (1998) Subcellular remodeling and heart dysfunction in chronic diabetes. Cardiovasc Res 40:239–247PubMedCrossRef

44.

McLean WG (1997) The role of axonal cytoskeleton in diabetic neuropathy. Neurochem Res 22:951–956PubMedCrossRef

45.

Murata C, Taniyama M, Kuriyama S et al (2004) Meta-analysis of three diabetes population studies: association of inactive ALDH2 genotype with maternal inheritance of diabetes. Diabetes Res Clin Pract 66(Suppl 1):S145–S147PubMedCrossRef

46.

Wadham C, Parker A, Wang L, Xia P (2007) High glucose attenuates protein S-nitrosylation in endothelial cells: role of oxidative stress. Diabetes 56:2715–2721PubMedCrossRef

47.

Witek B, Krol T, Kolataj A, Ochwanowska E, Stanislawska I, Slewa A (2001) The insulin, glucose and cholesterol level and activity of lysosomal enzymes in the course of the model alloxan diabetes. Neuro Endocrinol Lett 22:238–242PubMed

48.

Sreekumar R, Halvatsiotis P, Schimke JC, Nair KS (2002) Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment. Diabetes 51:1913–1920PubMedCrossRef

49.

Yokoyama T, Yamane K, Minamoto A et al (2006) High glucose concentration induces elevated expression of anti-oxidant and proteolytic enzymes in cultured human retinal pigment epithelial cells. Exp Eye Res 83:602–609PubMedCrossRef

50.

Turko IV, Marcondes S, Murad F (2001) Diabetes-associated nitration of tyrosine and inactivation of succinyl-CoA:3-oxoacid CoA-transferase. Am J Physiol Heart Circ Physiol 281:H2289–H2294PubMed

Titel: Human retinal pigment epithelium proteome changes in early diabetes
verfasst von: A. Decanini
P. R. Karunadharma
C. L. Nordgaard
X. Feng
T. W. Olsen
D. A. Ferrington
Publikationsdatum: 01.06.2008
Verlag: Springer-Verlag
Erschienen in: Diabetologia / Ausgabe 6/2008
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-008-0991-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2008

Diabetic podopathy—yes please! Reply to Boulton AJM, Armstrong DG, Baker NR et al. [letter]

Urinary mRNA expression of ACE and ACE2 in human type 2 diabetic nephropathy

Diabetic podopathy—no thanks!

Monitoring of glucose-regulated single insulin secretory granule movement by selective photoactivation

Genetic analysis of recently identified type 2 diabetes loci in 1,638 unselected patients with type 2 diabetes and 1,858 control participants from a Norwegian population-based cohort (the HUNT study)